QIAstat-Dx® Meningitis/Encephalitis Panel Performance Evaluation Study 001
NCT05092438 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 595
Last updated 2025-04-16
Summary
Study for performance evaluation of the QIAstat-Dx® Meningitis/Encephalitis Panel in comparison with other chosen comparator methods.
Conditions
- Meningitis/Encephalitis
Sponsors & Collaborators
-
QIAGEN Gaithersburg, Inc
lead INDUSTRY
Principal Investigators
-
Sarah Johnson · QIAGEN Gaithersburg, Inc
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-08
- Primary Completion
- 2021-12-02
- Completion
- 2021-12-02
Countries
- United Kingdom
Study Locations
More Related Trials
-
Searching for Persistence of Infection in Lyme Disease
NCT01143558 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seronegative Chronic Lyme Disease
NCT00000938 ·Status: COMPLETED ·Phase: PHASE3
-
Biomarker Study of Previously Treated Lyme Disease Volunteers in Comparison to Healthy Volunteers
NCT04835792 ·Status: UNKNOWN
-
Study of Lyme Neuroborreliosis
NCT01635530 ·Status: COMPLETED ·Phase: PHASE4
-
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seropositive Chronic Lyme Disease
NCT00001101 ·Status: COMPLETED ·Phase: PHASE3
-
Study on Early Lyme Neuroborreliosis
NCT00910533 ·Status: UNKNOWN ·Phase: NA
-
Doxycycline and Ceftriaxone in Suspected Early Lyme Neuroborreliosis
NCT00942006 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate the Safety and Immunogenicity of mRNA-1975 and mRNA-1982 Against Lyme Disease in Participants 18 Through 70 Years of Age
NCT05975099 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Lyme Disease Diagnostic Assay - Collection of Whole Blood
NCT05041595 ·Status: ENROLLING_BY_INVITATION
-
Aseptic Meningoencephalitis in Slovenia
NCT02328469 ·Status: UNKNOWN
-
A Study to Learn About Different Dosing Schedules of a Lyme Disease Vaccine in Healthy Adults
NCT07226882 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study and Treatment of Post Lyme Disease (STOP-LD)
NCT00000937 ·Status: COMPLETED ·Phase: PHASE3
-
64Cu-DOTATATE-PET for Lyme Neuroborreliosis
NCT06392815 ·Status: RECRUITING ·Phase: NA
-
Effects of Psilocybin in Post-Treatment Lyme Disease
NCT05305105 ·Status: COMPLETED ·Phase: PHASE1
-
Seroprevalence Study to Evaluate the Persistence of Anti-leptospira Antibody in Subjects Vaccinated With Spirolept® Vaccine
NCT03497572 ·Status: COMPLETED
-
Genetic Susceptibility and Biomarkers in Listeriosis
NCT02924220 ·Status: COMPLETED
-
Effect of Intravenous Ceftriaxone and Oral Doxycycline for Lyme Neuroborreliosis
NCT00138801 ·Status: COMPLETED ·Phase: PHASE3
-
Xenodiagnosis After Antibiotic Treatment for Lyme Disease
NCT02446626 ·Status: COMPLETED ·Phase: NA
-
The Burden of Lyme Disease (BOLD) in a Pandemic - Insights From an Online Cross-sectional and Prospective Cohort Survey
NCT05312619 ·Status: UNKNOWN
-
Six Versus Two Weeks Treatment With Doxycycline in Lyme Neuroborreliosis
NCT02553473 ·Status: COMPLETED ·Phase: PHASE3
-
Injection Sclerotherapy With Bleomycin VS Doxycycline in Patients With Lymphatic Malformations
NCT07320001 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 Years
NCT00161785 ·Status: COMPLETED ·Phase: PHASE4
-
Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children
NCT05634811 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicenter Real-life Study of Disseminated Borreliosis Cases Occurring in Patients Receiving Anti-CD20 Treatment in France
NCT07343089 ·Status: RECRUITING
-
First Clinical Study of the Safety and Blood Levels of a Human Monoclonal Antibody (2217LS) Against Lyme Disease Bacteria in Healthy People
NCT04863287 ·Status: COMPLETED ·Phase: PHASE1